GLP-1 Programs Using 503B FDA-Registered Pharmacies
The pharmacy making your medication matters more than the telehealth platform prescribing it. Here's why 503B matters.
- 503B facilities are FDA-registered and follow the same manufacturing standards as major drug companies.
- 503A pharmacies are state-regulated with widely varying quality — potency variations of 42–170% have been documented.
- Synergy Rx is the only GLP-1 program we've found with both 503B + PCAB accreditation.
- If a provider won't name their pharmacy, walk away.
If you're getting compounded GLP-1 medications, the single most important safety factor isn't the telehealth platform — it's the pharmacy that makes your medication. 503B FDA-registered outsourcing facilities operate under the same manufacturing standards as major drug companies. 503A pharmacies don't. Here's why it matters and which programs use 503B facilities.
503A vs. 503B: The Critical Difference
503B outsourcing facilities are registered with the FDA and inspected regularly. They must follow current Good Manufacturing Practices (cGMP), conduct batch testing for potency and sterility, and can produce medications at scale without individual prescriptions.
503A traditional compounding pharmacies are regulated by state boards, not the FDA. They compound patient-specific medications under USP <797> standards. Quality varies enormously — some are excellent, others have been caught with potency variations of 42–170%.
The FDA's March 2026 warning letters targeted providers using pharmacies that failed sterility testing, had contamination issues, or couldn't demonstrate consistent potency. Most were 503A facilities or unregistered operations.
GLP-1 Programs Using 503B Pharmacies
Synergy Rx — 503B + PCAB Accredited
Synergy Rx is the only GLP-1 telehealth program we've found that sources from a pharmacy holding both 503B FDA registration and PCAB accreditation (fewer than 1% of pharmacies achieve this). Their $200/month semaglutide and $299/month tirzepatide come with Certificates of Analysis available on request.
How to Verify a 503B Facility Yourself
- Ask the telehealth provider for the name of their compounding pharmacy.
- Visit the FDA's Registered Outsourcing Facilities list at FDA.gov.
- Search for the pharmacy name. If they're listed, they're 503B registered.
- Check the inspection history — look for any Form 483 observations or warning letters.
- Bonus: Search PCAB.org for accreditation status.
If a telehealth provider won't tell you which pharmacy compounds their medications, that's an immediate disqualifier. Transparency about pharmacy sourcing is the bare minimum.
Does 503B Guarantee Safety?
No. 503B registration means the pharmacy is subject to FDA oversight and must follow cGMP standards. It doesn't guarantee that every batch is perfect. But it dramatically reduces risk compared to unregistered or 503A-only operations. Think of it like the difference between a restaurant with a health inspection record and one operating out of someone's garage.
Bottom Line
If pharmacy safety is your top priority (and for injectable medications, it should be), Synergy Rx's 503B + PCAB combination is the highest standard available in the GLP-1 telehealth market. The $200/month cost is competitive with programs using less-regulated pharmacies — making it an easy recommendation for safety-conscious patients.
We independently verify LegitScript certification, 503B FDA registration, PCAB accreditation, BBB ratings, and FDA warning letter history. We earn affiliate commissions from listed providers, but rankings are editorial and independent of compensation.